MyAverix Finance
F · Healthcare
ALK-ABELLO AS DK -50 (4AJ0)
Biotechnology
ALK-ABELLO AS DK -50 (4AJ0) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 4AJ0
ALK-ABELLO AS DK -50 (4AJ0) — FAQ
What is 4AJ0's P/E ratio?
The price-to-earnings (P/E) ratio for ALK-ABELLO AS DK -50 (4AJ0) is 18.00 (data as of 2026-03-24).
Does ALK-ABELLO AS DK -50 pay a dividend?
Dividend yield is not available in the current snapshot for ALK-ABELLO AS DK -50 (4AJ0). Check the MyAverix Finance app for the latest dividend data.
What sector is ALK-ABELLO AS DK -50 in?
ALK-ABELLO AS DK -50 (4AJ0) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 4AJ0 listed on?
4AJ0 is listed on F.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.